Promoter and Institution shareholding for Astal Laboratories remains unchanged at 0%, indicating no confidence from smart money.

Public shareholding has declined significantly, with an 8.31% drop YoY and 5.10% QoQ, reflecting negative sentiment among retail investors.

In contrast, the sector averages show no change, suggesting that the selling in Astal Laboratories is not in line with sector performance, indicating potential isolated weakness.